NVO EPS Estimates
Novo Nordisk A/S
$40.70
-$0.68(-1.64%)
59
Overall
95
Value
45
Tech
39
Quality
Market Cap
$183.23B
Volume
6.51M
52W Range
$35.12 - $64.16
Target Price
$45.27
NVO EPS estimates: the consensus estimate for Novo Nordisk A/S's current fiscal year is $3.40 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NVO EPS Estimates
- EPS estimate, current quarter
- $0.68
- EPS estimate, next quarter
- $0.86
- EPS estimate, current year
- $3.40
- EPS estimate, next year
- $3.45
- EPS growth, 3-year
- +20.14%
| Fiscal year | EPS |
|---|---|
| 2016 | $14.99 |
| 2015 | $13.56 |
| 2014 | $10.10 |
| 2013 | $9.40 |
| 2012 | $7.82 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVO | $40.70 | -1.6% | 6.51M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |